Athol U. Wells

86.8k total citations · 16 hit papers
564 papers, 34.6k citations indexed

About

Athol U. Wells is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Pathology and Forensic Medicine. According to data from OpenAlex, Athol U. Wells has authored 564 papers receiving a total of 34.6k indexed citations (citations by other indexed papers that have themselves been cited), including 510 papers in Pulmonary and Respiratory Medicine, 200 papers in Physiology and 109 papers in Pathology and Forensic Medicine. Recurrent topics in Athol U. Wells's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (453 papers), Sarcoidosis and Beryllium Toxicity Research (175 papers) and Medical Imaging and Pathology Studies (109 papers). Athol U. Wells is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (453 papers), Sarcoidosis and Beryllium Toxicity Research (175 papers) and Medical Imaging and Pathology Studies (109 papers). Athol U. Wells collaborates with scholars based in United Kingdom, United States and Italy. Athol U. Wells's co-authors include David M. Hansell, Andrew G. Nicholson, Roland M. du Bois, Thomas V. Colby, Toby M. Maher, Sujal R. Desai, Elisabetta Renzoni, Christopher P. Denton, Luca Richeldi and Vincent Cottin and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

In The Last Decade

Athol U. Wells

534 papers receiving 33.9k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Nintedanib in Progressive Fibrosing Interstitial Lung Diseases

2019 1.3k citations Kevin R. Flaherty, Athol U. Wells et al. profile →
Idiopathic pulmonary fibrosis

2017 903 citations Fernando J. Martínez, Ganesh Raghu et al. profile →
Interstitial Lung Disease in Systemic Sclerosis

2008 815 citations Sujal R. Desai, David M. Hansell et al. American Journal of Respiratory and Critical Care Medicine profile →
Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy

2020 774 citations Peter M. George, Athol U. Wells et al. profile →
Diagnostic criteria for idiopathic pulmonary fibrosis: a Fleischner Society White Paper

2017 655 citations Kevin M. Brown, David M. Hansell et al. profile →
An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features

2015 655 citations Κατερίνα Αντωνίου, Kevin M. Brown et al. European Respiratory Journal profile →
Interstitial lung disease guideline

2008 624 citations Athol U. Wells et al. profile →
Histopathologic Subsets of Fibrosing Alveolitis in Patients with Systemic Sclerosis and Their Relationship to Outcome

2002 545 citations Demosthenes Bouros, Athol U. Wells et al. American Journal of Respiratory and Critical Care Medicine profile →
Idiopathic Pulmonary Fibrosis: A Composite Physiologic Index Derived from Disease Extent Observed by Computed Tomography

2003 495 citations Athol U. Wells, Sujal R. Desai et al. American Journal of Respiratory and Critical Care Medicine profile →
A multicenter, prospective, randomized, double‐blind, placebo‐controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma

2006 484 citations Sujal R. Desai, Athol U. Wells et al. profile →
Pulmonary Hypertension Due to Left Heart Diseases

2013 444 citations Vincent Cottin, Fernando J. Martínez et al. profile →
Pulmonary Hypertension in Chronic Lung Diseases

2013 438 citations Vincent Cottin, Fernando J. Martínez et al. profile →
Presentation, diagnosis and clinical course of the spectrum of progressive-fibrosing interstitial lung diseases

2018 386 citations Vincent Cottin, Athol U. Wells et al. profile →
The Role of Bacteria in the Pathogenesis and Progression of Idiopathic Pulmonary Fibrosis

2014 372 citations Philip L. Molyneaux, Athol U. Wells et al. American Journal of Respiratory and Critical Care Medicine profile →
Forced Vital Capacity in Patients with Idiopathic Pulmonary Fibrosis: Test Properties and Minimal Clinically Important Difference

2011 356 citations Roland M. du Bois, Athol U. Wells et al. American Journal of Respiratory and Critical Care Medicine profile →
Prediction of Pulmonary Complications and Long‐Term Survival in Systemic Sclerosis

2014 325 citations Athol U. Wells et al. profile →

Peers

Countries citing papers authored by Athol U. Wells

Since Specialization

Citations

This map shows the geographic impact of Athol U. Wells's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Athol U. Wells with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Athol U. Wells more than expected).

Fields of papers citing papers by Athol U. Wells

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Athol U. Wells. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Athol U. Wells. The network helps show where Athol U. Wells may publish in the future.

Co-authorship network of co-authors of Athol U. Wells

This figure shows the co-authorship network connecting the top 25 collaborators of Athol U. Wells. A scholar is included among the top collaborators of Athol U. Wells based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Athol U. Wells. Athol U. Wells is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Outcomes of Cardiac Resynchronization Therapy (CRT) in Cardiac Sarcoidosis Patients with a Range of Ejection Fractions 2024 ·ESC Heart Failure ·Alexander Liu, Raheel Ahmed, (unknown), (unknown), (unknown), Kamleshun Ramphul, Rui Shi, (unknown), (unknown), Kshama Wechalekar, Rajdeep Khattar, Peter L. Collins, Athol U. Wells, Vasileios Kouranos, Rakesh Sharma	6
2	Identification of progressive pulmonary fibrosis: consensus findings from a modified Delphi study 2024 ·Respiratory Research ·Athol U. Wells, Simon Walsh, Ayodeji Adegunsoye, Vincent Cottin, Sonye K. Danoff, Anand Devaraj, Kevin R. Flaherty, Peter M. George, Kerri A. Johannson, Martin Kolb, Yasuhiro Kondoh, Andrew G. Nicholson, Sara Tomassetti, Elizabeth R. Volkmann, Kevin K. Brown	3
3	Cardiac sarcoidosis and neurosarcoidosis – multidisciplinary approach for diagnosis 2024 ·Current Opinion in Pulmonary Medicine ·Vasileios Kouranos, Rakesh Sharma, Athol U. Wells, Victoria Singh‐Curry	0
4	The impact of hiatus hernia in hypersensitivity pneumonitis 2024 ·Respirology ·(unknown), Carmel Stock, (unknown), Gísli Jenkins, Felix Chua, Philip L. Molyneaux, Anand Devaraj, Vasileios Kouranos, Athol U. Wells, Elisabetta Renzoni, Simon Padley, Sujal R. Desai, Peter M. George	0
5	Serum C‐reactive protein is associated with earlier mortality across different interstitial lung diseases 2023 ·Respirology ·Carmel Stock, (unknown), Vasileios Kouranos, Joseph Jacob, Maria Kokosi, Peter M. George, Felix Chua, Athol U. Wells, Piersante Sestini, Elisabetta Renzoni	13
6	Predictors of mortality in subjects with progressive fibrosing interstitial lung diseases 2022 ·Respirology ·Kevin K. Brown, Yoshikazu Inoue, Kevin R. Flaherty, Fernando J. Martínez, Vincent Cottin, Francesco Bonella, Stefania Cerri, Sonye K. Danoff, S. Jouneau, (unknown), Martin Schmidt, Susanne Stowasser, Rozsa Schlenker‐Herceg, Athol U. Wells	29
7	Short‐term lung function changes predict mortality in patients with fibrotic hypersensitivity pneumonitis 2022 ·Respirology ·Claudio Macaluso, Cristina Boccabella, Maria Kokosi, (unknown), Vasileios Kouranos, Peter M. George, George Margaritopoulos, Philip L. Molyneaux, Felix Chua, Toby M. Maher, Gísli Jenkins, Andrew G. Nicholson, Sujal R. Desai, Anand Devaraj, Athol U. Wells, Elisabetta Renzoni, Carmel Stock	12
8	Muscle stimulation in advanced idiopathic pulmonary fibrosis: a randomised placebo-controlled feasibility study 2021 ·BMJ Open ·Claire M. Nolan, Suhani Patel, Ruth E Barker, Jessica A. Walsh, (unknown), Matthew Maddocks, Peter M. George, Elisabetta Renzoni, Athol U. Wells, Philip L. Molyneaux, Vasileios Kouranos, Felix Chua, Toby M. Maher, William D‐C Man	10
9	The DIAMORFOSIS (DIAgnosis and Management Of lung canceR and FibrOSIS) survey: international survey and call for consensus 2020 ·ERJ Open Research ·Αrgyris Τzouvelekis, Κατερίνα Αντωνίου, Michael Kreuter, Matthew Evison, Torsten Blum, Venerino Poletti, Bogdan Grigoriu, Carlo Vancheri, Paolo Spagnolo, Τheodoros Karampitsakos, Francesco Bonella, Athol U. Wells, Ganesh Raghu, María Molina‐Molina, Daniel A. Culver, Elisabeth Bendstrup, Nesrin Moğulkoç, Stefano Elia, Jacquès Cadranel, Demosthenes Bouros	26
10	Pulmonary hypertension in interstitial lung disease: Limitations of echocardiography compared to cardiac catheterization 2018 ·Respirology ·Gregory J. Keir, Stephen J. Wort, Maria Kokosi, Peter M. George, Simon Walsh, Joseph Jacob, Laura Price, Simon Bax, Elisabetta Renzoni, Toby M. Maher, Peter S. Macdonald, David M. Hansell, Athol U. Wells	45
11	Lung function outcomes in the INPULSIS® trials of nintedanib in idiopathic pulmonary fibrosis 2018 ·Respiratory Medicine ·Kevin M. Brown, Kevin R. Flaherty, Vincent Cottin, Ganesh Raghu, Yoshikazu Inoue, Arata Azuma, John T. Huggins, Luca Richeldi, Susanne Stowasser, Wibke Stansen, Rozsa Schlenker‐Herceg, Toby M. Maher, Athol U. Wells	26
12	Likelihood of pulmonary hypertension in patients with idiopathic pulmonary fibrosis and emphysema 2017 ·Respirology ·Joseph Jacob, Brian J. Bartholmai, Srinivasan Rajagopalan, Ronald A. Karwoski, Arjun Nair, Simon Walsh, Joseph Barnett, Gary Cross, Eoin P. Judge, Maria Kokosi, Elisabetta Renzoni, Toby M. Maher, Athol U. Wells	27
13	MiR-185/AKT and miR-29a/Collagen 1a pathways are activated in IPF BAL cells 2016 ·Oncotarget ·Eliza Tsitoura, Athol U. Wells, Konstantinos Karagiannis, Ismini Lasithiotaki, Eirini Vasarmidi, Eleni Bibaki, (unknown), Hiroe Sato, Demetrios�� Spandidos, Nikolaos M. Siafakas, George Sourvinos, Κατερίνα Αντωνίου	23
14	Bosentan in pulmonary hypertension associated with fibrotic idiopathic interstitial pneumonia: A randomized, double-blind, placebo-controlled study 2013 ·European Respiratory Journal ·Gregory J. Keir, Tamera J. Corte, Lisa Parfitt, Toby M. Maher, (unknown), Elisabetta Renzoni, Konstantinos Dimopoulos, Michael Α. Gatzoulis, (unknown), Luke Howard, Paul A. Corris, Katherine Ma O’Reilly, (unknown), Surinder S. Birring, Athol U. Wells, SJ Wort	3
15	Elevated nocturnal desaturation index predicts mortality in interstitial lung disease. 2012 ·PubMed ·Tamera J. Corte, Stephen J. Wort, Susan Talbot, Peter M. Macdonald, (unknown), Michael I. Polkey, Elisabetta Renzoni, Toby M. Maher, A.G. Nicholson, Athol U. Wells	37
16	Specialist Palliative Care is More Than Drugs: A Retrospective Study of ILD Patients 2011 ·European Respiratory Journal ·Sabrina Bajwah, Irene J Higginson, Joy Ross, Athol U. Wells, Surinder S. Birring, Amit Patel, Julia Riley	3
17	C-C Chemokine Receptor 5 Gene Variants in Relation to Lung Disease in Sarcoidosis 2005 ·American Journal of Respiratory and Critical Care Medicine ·Paolo Spagnolo, Elisabetta Renzoni, Athol U. Wells, Susan J. Copley, Sujal R. Desai, Hiroe Sato, Jan C. Grutters, Atiyeh M. Abdallah, Anne B. Taegtmeyer, Roland M. du Bois, Kenneth I. Welsh	48
18	Six-Minute Walk, Maximal Exercise Tests 2005 ·American Journal of Respiratory and Critical Care Medicine ·Tam Eaton, Pam Young, David Milne, Athol U. Wells	210
19	C-C Chemokine Receptor 2 and Sarcoidosis 2003 ·American Journal of Respiratory and Critical Care Medicine ·Paolo Spagnolo, Elisabetta Renzoni, Athol U. Wells, Hiroe Sato, Jan C. Grutters, Piersante Sestini, Atiyeh M. Abdallah, E Gramiccioni, Henk J.T. Ruven, Roland M. du Bois, Kenneth I. Welsh	81
20	Job satisfaction of public health nurses: is there a predictable decline? 1994 ·PubMed ·(unknown), (unknown), (unknown), Athol U. Wells	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact